These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32377187)

  • 1. Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
    Cappelli C; Pirola I; Gandossi E; Rotondi M; Lombardi D; Casella C; Marini F; Saullo M; Agosti B; Di Lodovico E; Chiovato L; Ferlin A; Castellano M
    Int J Endocrinol; 2020; 2020():7543930. PubMed ID: 32377187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum TSH Level as a Simple Efficient Tool to Assess the Risk of Thyroid Malignancy in Euthyroid Patients with Indeterminate Cytology - A Cohort Study.
    Vinod A; Ramachandran R; Pillai AV; Padmanabhan DS; Ravindran GC; Babu MJC; Jacob P; Nair GC
    Indian J Endocrinol Metab; 2022; 26(5):446-452. PubMed ID: 36618514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of fine-needle aspiration cytology for thyroid nodules is not affected by coexistent chronic autoimmune thyroiditis: results from a cyto-histological series of patients with indeterminate cytology.
    Rotondi M; Molteni M; Cappelli C; Croce L; Caputo A; Groppelli G; Liboà F; Guazzoni V; Villani L; Zeppa P; Chiovato L
    Eur J Endocrinol; 2021 Jun; 185(2):201-208. PubMed ID: 34048364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indeterminate thyroid nodules (TIR3A/TIR3B) according to the new Italian reporting system for thyroid cytology: A cytomorphological study.
    Rullo E; Minelli G; Bosco D; Nardi F; Grani G; Durante C; Ascoli V
    Cytopathology; 2019 Sep; 30(5):475-484. PubMed ID: 31112332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum TSH as a predictor of malignancy in indeterminate thyroid nodules.
    Amado A; Castro B; Torre AP; Graça S; Tavares A; Póvoa A; Soares C; Gonçalves G
    Ann R Coll Surg Engl; 2022 May; 104(5):380-384. PubMed ID: 34939834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uni- and Multivariate Analyses of Cancer Risk in Cytologically Indeterminate Thyroid Nodules: A Single-Center Experience.
    Battistella E; Mirabella M; Pomba L; Toniato R; Giacomini F; Magni G; Toniato A
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
    Kyrilli A; Tacelli N; Russo L; Lebrun L; Salmon I; Russ G; Moreno-Reyes R; Corvilain B
    Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37992294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Use of Raman Spectroscopy Improves Diagnostic Accuracy for Indeterminate Thyroid Nodules.
    Palermo A; Sodo A; Naciu AM; Di Gioacchino M; Paolucci A; di Masi A; Maggi D; Crucitti P; Longo F; Perrella E; Taffon C; Verri M; Ricci MA; Crescenzi A
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3309-3319. PubMed ID: 36103268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology.
    Adhami M; Michail P; Rao A; Bhatt CR; Grodski S; Serpell JW; Lee JC
    World J Surg; 2020 Feb; 44(2):363-370. PubMed ID: 31502005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.
    Kim ES; Lim DJ; Baek KH; Lee JM; Kim MK; Kwon HS; Song KH; Kang MI; Cha BY; Lee KW; Son HY
    Thyroid; 2010 Aug; 20(8):885-91. PubMed ID: 20465529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid scintigraphy in the era of fine-needle aspiration cytology.
    Pirola I; Di Lodovico E; Casella C; Pezzaioli L; Facondo P; Ferlin A; Lombardi D; Cappelli C
    Clin Endocrinol (Oxf); 2020 Dec; ():. PubMed ID: 33350500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound Parameters Can Accurately Predict the Risk of Malignancy in Patients with "Indeterminate TIR3b" Cytology Nodules: A Prospective Study.
    Guarnotta V; La Monica R; Ingrao VR; Di Stefano C; Salzillo R; Pizzolanti G; Giannone AG; Almasio PL; Richiusa P; Giordano C
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-Up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment?
    Ianni F; Pascucci D; Paragliola RM; Rota CA; Perotti G; Fadda G; Pontecorvi A; Corsello SM
    Thyroid; 2020 Jan; 30(1):65-71. PubMed ID: 31552809
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
    Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
    Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.
    Al Dawish MA; Alwin Robert A; Thabet MA; Braham R
    Cancer Inform; 2018; 17():1176935118765132. PubMed ID: 29581701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
    Jonklaas J; Nsouli-Maktabi H; Soldin SJ
    Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients.
    Alaraifi AK; Alessa M; Hijazi LO; Alayed AM; Alsalem AA
    Acta Otorhinolaryngol Ital; 2023 Jun; 43(3):183-188. PubMed ID: 37204842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of ultrasound and cytological classification system to predict the malignancy of thyroid nodules with indeterminate cytology.
    Maia FF; Matos PS; Pavin EJ; Vassallo J; Zantut-Wittmann DE
    Endocr Pathol; 2011 Jun; 22(2):66-73. PubMed ID: 21547508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.